Skip to main content
. 2020 May 3;52(6):971–977.e3. doi: 10.1016/j.immuni.2020.04.023

Figure 2.

Figure 2

Measurement of Neutralizing Antibody Titers in COVID-19 Convalescent Individuals

(A) Correlation analysis of neutralizing antibody titers in COV1D-19 patients measured by pseudovirus and live SARS-CoV-2 (n = 20).

(B) Neutralizing curves of 14 COVID-19 patients measured by pseudovirus-based assay. The experiment with patients was performed in triplicates. The experiment with healthy donors was performed in duplicates.

(C) Measurement of neutralizing antibody titers of 14 COVID-19 patients by pseudovirus-based assay.

(D) Correlation between NAT50 and AUC of anti-S-RBD (left) and anti-NP (right) IgG (n = 14).

HD, healthy donor; Pt, patient; AUC, area under curve; NAT50, neutralizing antibody titers. Date are presented as mean ± SEM. p < 0.05, 0.05 < ∗∗p < 0.001, ∗∗∗p < 0.001.